Trillium Therapeutics Inc (TRIL)

[NY1972]

CELG should have data by ASH, they found a good dose before 2/5/2016 with 2/6 + 3/3 centers recruiting.


Brief title: A Study of CC-90002 in Subjects With Acute Myeloid Leukemia (AML) and High-risk Myelodysplastic Syndrome (MDS)
2015_12_28 Study Nothing (earliest version on record)
2016_02_05 Study Changes Protocol, Recruitment, Location/Contact, Administrative, Misc.
2016_02_16 Study Changes Recruitment status, Location/Contact, Misc.
2016_03_29 Study Changes Recruitment, Location/Contact, Misc.
2016_04_12 Study Changes Recruitment, Location/Contact, Misc.
2016_05_04 Study Changes Recruitment, Misc.

A Phase 1, Dose Finding Study of CC-90002 in Subjects With Advanced Solid and Hematologic Cancers

2015_02_19 Study Nothing (earliest version on record)
2015_02_22 Study Changes Recruitment, Administrative
2015_04_02 Study Changes Protocol, Recruitment status, Recruitment, Location/Contact, Misc.
2015_05_03 Study Changes Protocol, Recruitment, Location/Contact, Misc.
2015_05_04 Study Changes Recruitment, Misc.
2015_09_15 Study Changes Recruitment, Location/Contact, Misc.
2015_10_07 Study Changes Protocol, Recruitment, Administrative, Misc.
2016_02_05 Study Changes Protocol, Recruitment, Misc.
2016_02_23 Study Changes Recruitment, Misc.
2016_03_30 Study Changes Recruitment, Misc.